TYRA
Tyra Biosciences Inc
NASDAQ: TYRA · HEALTHCARE · BIOTECHNOLOGY
$34.75
+2.86% today
Updated 2026-04-30
Market cap
$2.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.01
Dividend yield
—
52W range
$9 – $41
Volume
1.2M
Tyra Biosciences Inc (TYRA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $528000.00 | $16.01M | $306.70M | $266.18M | $225.86M | $363.56M |
| Cash & equivalents | — | — | — | — | — | — |
| Current assets | $127000.00 | $15.28M | $304.06M | $257.29M | $211.67M | $347.46M |
| Total liabilities | $5.27M | $29.65M | $4.96M | $8.35M | $21.59M | $20.41M |
| Current liabilities | $5.16M | $1.86M | $3.62M | $5.70M | $15.33M | $14.59M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — |
| Retained earnings | $-4.74M | $-14.08M | $-40.37M | $-95.70M | $-164.83M | $-251.31M |
| Accounts receivable | — | — | — | — | $700000.00 | $2.00M |
| Inventory | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |